ReWalk Robotics

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

ReWalk Robotics Ltd. (LFWD) Q4 2023 Earnings Call Transcript

ReWalk Robotics (LFWD) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.09 per share a year ago.

ReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue Estimates

ReWalk Robotics Ltd

Lifeward brand reflects the Company's commitment to pioneering innovative technology to empower the pursuit of life's ambitions in the face of physical limitation or disability

ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward

Apple

Abbott Labs

Best Buy

Cigna

Microsoft

Teladoc

While it doesn't seem like it when you're young, aging happens to everyone and therefore, so-called AgeTech stocks should benefit from inevitability. A buzzword for age-related technology, this concept refers to a rapidly growing field focused on developing and applying innovative solutions to improve the lives of senior citizens.

7 ‘AgeTech' Stocks to Profit From the Booming Longevity Market

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, announced today that the Company is expanding its direct sales coverage to Canada. This expansion occurs as the result of the integration between the former ReWalk and AlterG commercial teams following the recent acquisition, which has resulted in a more extensive sales force with increased capacity.

ReWalk Robotics Expands Direct Sales Coverage to Canada

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at the Sidoti January Virtual Investor Conference, taking place on January 17-18, 2024.

ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17

ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury

First ReWalk Personal Exoskeleton Claim Paid by Medicare

ReWalk supports “gap-filling” pricing method proposed by CMS with use of up-to-date pricing information. ReWalk supports “gap-filling” pricing method proposed by CMS with use of up-to-date pricing information.

ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting

AC Immune

Clearsign Combustion

Heron Therapeutics

Perpetua Resources Corp

PowerFleet Inc

Synchronoss

Undeniably, the concept of growth penny stocks represent one of the hottest topics on Wall Street. And this interest goes well beyond the meme-stock phenomenon that characterized much of the market action during the post-pandemic period.

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth

R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype

ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype

Destination XL Group

Ford Motor Company

Kinross Gold

SoundHound AI Inc

United Microelectronics

Navigating Wall Street's topsy-turvy landscape since 2020 has been a voyage filled with unexpected twists and turns. It's been incredibly challenging, from the depths of the coronavirus market crash to the peaks of a buoyant bull market, followed by another bearish downturn.

7 Cheap Stocks to Buy Now if You Have $100 to Spend: November Edition

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants Mike Lawless - Chief Financial Officer Larry Jasinski - Chief Executive Officer Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (RWLK) Q3 2023 Earnings Call Transcript

Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts to Attain Medicare Payment Coverage of Exoskeletons MARLBOROUGH, Mass., BERLIN and YOKNEAM ILLIT, Israel, Nov. 14, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.

ReWalk Robotics Reports Third Quarter 2023 Financial Results

Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons

New Bill Facilitates Veteran Access to Powered Exoskeletons

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023, prior to the U.S. financial markets open.

ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023

2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons. Final rule expedites access for Medicare beneficiaries to exoskeleton technology that enables individuals with spinal cord injury to stand, walk, and navigate stairs and curbs in everyday life.

Medicare Coverage Solidified for ReWalk Personal Exoskeleton

Broadwind Energy

When it comes to extremely speculative, low-priced securities, you need to exercise extreme caution, even if they're labeled as the best penny stocks to buy. Consider this term as euphemism for don't buy these incredibly risky ideas unless you perform extensive due diligence.

The 3 Best Penny Stocks to Buy in November

A key theme for the event is that 2023 marks “The Year to imagine AI in Everything”. A key theme for the event is that 2023 marks “The Year to imagine AI in Everything”.

ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 20, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its gratitude to Yohanan Engelhardt for his many contributions to ReWalk, as he will no longer serve as a director. Mr. Engelhardt had served on ReWalk's Board of Directors as chairman of the audit committee for over five years with exemplary performance.

ReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable Contributions

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 06, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief Executive Officer, will present and host one-on-one meetings with investors virtually at the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023.

ReWalk Robotics Ltd. to Present Virtually at H.C.

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept.

ReWalk Robotics Announces Additional Change to Board of Directors

Combined Company Expected to Expand Access for Patients to Innovative Rehabilitation Technologies for Use in Clinics and the Home

ReWalk Robotics Announces Closing of Acquisition of AlterG

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (RWLK) Q2 2023 Earnings Call Transcript

ReWalk Robotics (RWLK) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.07 per share a year ago.

ReWalk Robotics (RWLK) Reports Q2 Loss, Tops Revenue Estimates

Revenue in Line with Prior Financial Guidance Continued Progress with CMS in Establishment of Medicare Benefit Category for Exoskeletons Pending Acquisition of AlterG Expected to Contribute to ReWalk Financial Results Starting in Q3'23 MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Aug. 11, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.

News for ReWalk Robotics Stock (RWLK)